On September 1, 2020, ACEA Biosciences officially joins the Agilent Technologies family. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses.
While the transition will involve minor changes in how ACEA customers order products, one thing will not change: our commitment to delivering the same high level of customer service that you have come to expect from us. Our priority is to minimize disruption to customers, partners, and employees.
Agilent NovoCyte flow cytometers offer high quality data in an easy-to-use platform to save researchers time when acquiring and analyzing experimental data.
Agilent xCELLigence Real-Time Cell Analysis (RTCA) instruments use biosensors to continuously monitor cell behavior in a label-free manner.